Interaction between HNF4A polymorphisms and physical activity in relation to type 2 diabetes-related traits: Results from the Quebec Family Study

Diabetes Research and Clinical Practice

Volumn 84, Issue 3, 2009, Pages 211-218

  Stephanie May, Ruchat ^a,c   John, Weisnagel S ^a,c   Tuomo, Rankinen ^b   Claude, Bouchard ^b   Marie Claude, Vohl ^c   Louis, Pérusse ^a,c  

^a UNIVERSITÉ LAVAL   (Canada)

^b PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^c LAVAL UNIVERSITY   (Canada)

Author keywords

Hepatocyte nuclear factor 4 ; Interaction; Physical activity; Polymorphisms; T2DM related phenotypes

Indexed keywords

C PEPTIDE; GLUCOSE; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; INSULIN;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; DIET RESTRICTION; DISEASE ASSOCIATION; FEMALE; GENETIC ASSOCIATION; GENOTYPE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; INSULIN BLOOD LEVEL; INSULIN RELEASE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PHYSICAL ACTIVITY; QUESTIONNAIRE; SINGLE NUCLEOTIDE POLYMORPHISM;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; EXERCISE; GLUCOSE TOLERANCE TEST; HEPATOCYTE NUCLEAR FACTOR 4; HUMANS; MOTOR ACTIVITY; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; QUEBEC;

EID: 67349166481     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2009.03.012     Document Type: Article

References (50)

1. Weyer C., Tataranni P.A., Bogardus C., and Pratley R.E. Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type 2 diabetes development. Diab. Care 24 (2001) 89-94
2. Odom D.T., Zizlsperger N., Gordon D.B., Bell G.W., Rinaldi N.J., Murray H.L., et al. Control of pancreas and liver gene expression by HNF transcription factors. Science 303 (2004) 1378-1381
3. Stoffel M., and Duncan S.A. The maturity-onset diabetes of the young (MODY1) transcription factor HNF4alpha regulates expression of genes required for glucose transport and metabolism. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 13209-13214
4. Ladias J.A., Hadzopoulou-Cladaras M., Kardassis D., Cardot P., Cheng J., Zannis V., et al. Transcriptional regulation of human apolipoprotein genes ApoB, ApoCIII, and ApoAII by members of the steroid hormone receptor superfamily HNF-4, ARP-1, EAR-2, and EAR-3. J. Biol. Chem. 267 (1992) 15849-15860
5. Wang H., Maechler P., Antinozzi P.A., Hagenfeldt K.A., and Wollheim C.B. Hepatocyte nuclear factor 4alpha regulates the expression of pancreatic beta-cell genes implicated in glucose metabolism and nutrient-induced insulin secretion. J. Biol. Chem. 275 (2000) 35953-35959
6. Thomas H., Jaschkowitz K., Bulman M., Frayling T.M., Mitchell S.M., Roosen S., et al. A distant upstream promoter of the HNF-4alpha gene connects the transcription factors involved in maturity-onset diabetes of the young. Hum. Mol. Genet. 10 (2001) 2089-2097
7. Love-Gregory L.D., Wasson J., Ma J., Jin C.H., Glaser B., Suarez B.K., et al. A common polymorphism in the upstream promoter region of the hepatocyte nuclear factor-4 alpha gene on chromosome 20q is associated with type 2 diabetes and appears to contribute to the evidence for linkage in an ashkenazi Jewish population. Diabetes 53 (2004) 1134-1140
8. Silander K., Mohlke K.L., Scott L.J., Peck E.C., Hollstein P., Skol A.D., et al. Genetic variation near the hepatocyte nuclear factor-4 alpha gene predicts susceptibility to type 2 diabetes. Diabetes 53 (2004) 1141-1149
9. Bonnycastle L.L., Willer C.J., Conneely K.N., Jackson A.U., Burrill C.P., Watanabe R.M., et al. Common variants in maturity-onset diabetes of the young genes contribute to risk of type 2 diabetes in Finns. Diabetes 55 (2006) 2534-2540
10. Damcott C.M., Hoppman N., Ott S.H., Reinhart L.J., Wang J., Pollin T.I., et al. Polymorphisms in both promoters of hepatocyte nuclear factor 4-alpha are associated with type 2 diabetes in the Amish. Diabetes 53 (2004) 3337-3341
11. Hansen S.K., Rose C.S., Glumer C., Drivsholm T., Borch-Johnsen K., Jorgensen T., et al. Variation near the hepatocyte nuclear factor (HNF)-4alpha gene associates with type 2 diabetes in the Danish population. Diabetologia 48 (2005) 452-458
12. Lehman D.M., Richardson D.K., Jenkinson C.P., Hunt K.J., Dyer T.D., Leach R.J., et al. P2 promoter variants of the hepatocyte nuclear factor 4alpha gene are associated with type 2 diabetes in Mexican Americans. Diabetes 56 (2007) 513-517
13. Weedon M.N., Owen K.R., Shields B., Hitman G., Walker M., McCarthy M.I., et al. Common variants of the hepatocyte nuclear factor-4alpha P2 promoter are associated with type 2 diabetes in the U.K. population. Diabetes 53 (2004) 3002-3006
14. Andrulionyte L., Laukkanen O., Chiasson J.L., and Laakso M. Single nucleotide polymorphisms of the HNF4alpha gene are associated with the conversion to type 2 diabetes mellitus: the STOP-NIDDM trial. J. Mol. Med. 84 (2006) 701-708
15. Yokoi N., Kanamori M., Horikawa Y., Takeda J., Sanke T., Furuta H., et al. Association studies of variants in the genes involved in pancreatic beta-cell function in type 2 diabetes in Japanese subjects. Diabetes 55 (2006) 2379-2386
16. Bagwell A.M., Bento J.L., Mychaleckyj J.C., Freedman B.I., Langefeld C.D., and Bowden D.W. Genetic analysis of HNF4A polymorphisms in Caucasian-American type 2 diabetes. Diabetes 54 (2005) 1185-1190
17. Vaxillaire M., Dina C., Lobbens S., Dechaume A., Vasseur-Delannoy V., Helbecque N., et al. Effect of common polymorphisms in the HNF4alpha promoter on susceptibility to type 2 diabetes in the French Caucasian population. Diabetologia 48 (2005) 440-444
18. Winckler W., Graham R.R., de Bakker P.I., Sun M., Almgren P., Tuomi T., et al. Association testing of variants in the hepatocyte nuclear factor 4alpha gene with risk of type 2 diabetes in 7,883 people. Diabetes 54 (2005) 886-892
19. Laukkanen O., Lindstrom J., Eriksson J., Valle T.T., Hamalainen H., Ilanne-Parikka P., et al. Polymorphisms in the SLC2A2 (GLUT2) gene are associated with the conversion from impaired glucose tolerance to type 2 diabetes: the Finnish Diabetes Prevention Study. Diabetes 54 (2005) 2256-2260
20. Ek J., Andersen G., Urhammer S.A., Gaede P.H., Drivsholm T., Borch-Johnsen K., et al. Mutation analysis of peroxisome proliferator-activated receptor-gamma coactivator-1 (PGC-1) and relationships of identified amino acid polymorphisms to Type II diabetes mellitus. Diabetologia 44 (2001) 2220-2226
21. Hara K., Horikoshi M., Kitazato H., Ito C., Noda M., Ohashi J., et al. Hepatocyte nuclear factor-4alpha P2 promoter haplotypes are associated with type 2 diabetes in the Japanese population. Diabetes 55 (2006) 1260-1264
22. Muller Y.L., Infante A.M., Hanson R.L., Love-Gregory L., Knowler W., Bogardus C., et al. Variants in hepatocyte nuclear factor 4alpha are modestly associated with type 2 diabetes in Pima Indians. Diabetes 54 (2005) 3035-3039
23. Barroso I., Luan J., Wheeler E., Whittaker P., Wasson J., Zeggini E., et al. Population-specific risk of type 2 diabetes conferred by HNF4A P2 promoter variants: a lesson for replication studies. Diabetes 57 (2008) 3161-3165
24. Johansson S., Raeder H., Eide S.A., Midthjell K., Hveem K., Sovik O., et al. Studies in 3,523 Norwegians and meta-analysis in 11,571 subjects indicate that variants in the hepatocyte nuclear factor 4 alpha (HNF4A) P2 region are associated with type 2 diabetes in Scandinavians. Diabetes 56 (2007) 3112-3117
25. Ioannidis J.P., Ntzani E.E., Trikalinos T.A., and Contopoulos-Ioannidis D.G. Replication validity of genetic association studies. Nat Genet 29 (2001) 306-309
26. Lasky-Su J., Lyon H.N., Emilsson V., Heid I.M., Molony C., Raby B.A., et al. On the replication of genetic associations: timing can be everything!. Am. J. Hum. Genet. 82 (2008) 849-858
27. Franks P.W., Mesa J.L., Harding A.H., and Wareham N.J. Gene-lifestyle interaction on risk of type 2 diabetes. Nutr. Metab. Cardiovasc. Dis. 17 (2007) 104-124
28. Franks P.W., Luan J., Browne P.O., Harding A.H., O'Rahilly S., Chatterjee V.K., et al. Does peroxisome proliferator-activated receptor gamma genotype (Pro12ala) modify the association of physical activity and dietary fat with fasting insulin level?. Metabolism 53 (2004) 11-16
29. Kilpelainen T.O., Lakka T.A., Laaksonen D.E., Lindstrom J., Eriksson J.G., Valle T.T., et al. SNPs in PPARG associate with type 2 diabetes and interact with physical activity. Med. Sci. Sports Exerc. 40 (2008) 25-33
30. Nelson T.L., Fingerlin T.E., Moss L.K., Barmada M.M., Ferrell R.E., and Norris J.M. Association of the peroxisome proliferator-activated receptor gamma gene with type 2 diabetes mellitus varies by physical activity among non-Hispanic whites from Colorado. Metabolism 56 (2007) 388-393
31. Kilpelainen T.O., Lakka T.A., Laaksonen D.E., Laukkanen O., Lindstrom J., Eriksson J.G., et al. Physical activity modifies the effect of SNPs in the SLC2A2 (GLUT2) and ABCC8 (SUR1) genes on the risk of developing type 2 diabetes. Physiol. Genom. 31 (2007) 264-272
32. de Luis D.A., Gonzalez Sagrado M., Aller R., Izaola O., and Conde R. Influence of the Trp64Arg polymorphism in the beta 3 adrenoreceptor gene on insulin resistance, adipocytokine response, and weight loss secondary to lifestyle modification in obese patients. Eur. J. Intern. Med. 18 (2007) 587-592
33. Laaksonen D.E., Siitonen N., Lindstrom J., Eriksson J.G., Reunanen P., Tuomilehto J., et al. Physical activity, diet, and incident diabetes in relation to an ADRA2B polymorphism. Med. Sci. Sports Exerc. 39 (2007) 227-232
34. Lakka T.A., Rankinen T., Weisnagel S.J., Chagnon Y.C., Lakka H.M., Ukkola O., et al. Leptin and leptin receptor gene polymorphisms and changes in glucose homeostasis in response to regular exercise in nondiabetic individuals: the HERITAGE family study. Diabetes 53 (2004) 1603-1608
35. Bouchard C. Genetic epidemiology, association and sib-pair linkage: results from the Quebec Family Study. In: Bray G., and Ryan D. (Eds). Molecular and Genetic Aspects of Obesity (1994), Louisiana State University Press, Baton Rouge, LA 470-481
36. Rice T., Nadeau A., Perusse L., Bouchard C., and Rao D.C. Familial correlations in the Quebec family study: cross-trait familial resemblance for body fat with plasma glucose and insulin. Diabetologia 39 (1996) 1357-1364
37. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
38. Aissani B., Perusse L., Lapointe G., Chagnon Y.C., Bouchard L., Walts B., et al. A quantitative trait locus for body fat on chromosome 1q43 in French Canadians: linkage and association studies. Obesity (Silver Spring) 14 (2006) 1605-1615
39. O'Connell J.R., and Weeks D.E. PedCheck: a program for identification of genotype incompatibilities in linkage analysis. Am. J. Hum. Genet. 63 (1998) 259-266
40. Devlin B., and Risch N. A comparison of linkage disequilibrium measures for fine-scale mapping. Genomics 29 (1995) 311-322
41. Fajans S.S., Bell G.I., and Polonsky K.S. Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N. Engl. J. Med. 345 (2001) 971-980
42. Boule N.G., Weisnagel S.J., Lakka T.A., Tremblay A., Bergman R.N., Rankinen T., et al. Effects of exercise training on glucose homeostasis: the HERITAGE Family Study. Diab. Care 28 (2005) 108-114
43. Gautier-Stein A., Zitoun C., Lalli E., Mithieux G., and Rajas F. Transcriptional regulation of the glucose-6-phosphatase gene by cAMP/vasoactive intestinal peptide in the intestine. Role of HNF4alpha, CREM, HNF1alpha, and C/EBPalpha. J. Biol. Chem. 281 (2006) 31268-31278
44. Yamamoto T., Shimano H., Nakagawa Y., Ide T., Yahagi N., Matsuzaka T., et al. SREBP-1 interacts with hepatocyte nuclear factor-4 alpha and interferes with PGC-1 recruitment to suppress hepatic gluconeogenic genes. J. Biol. Chem. 279 (2004) 12027-12035
45. Adamson A.W., Suchankova G., Rufo C., Nakamura M.T., Teran-Garcia M., Clarke S.D., et al. Hepatocyte nuclear factor-4alpha contributes to carbohydrate-induced transcriptional activation of hepatic fatty acid synthase. Biochem. J. 399 (2006) 285-295
46. Duncan G.E., Perri M.G., Theriaque D.W., Hutson A.D., Eckel R.H., and Stacpoole P.W. Exercise training, without weight loss, increases insulin sensitivity and postheparin plasma lipase activity in previously sedentary adults. Diab. Care 26 (2003) 557-562
47. Wong M.Y., Day N.E., Luan J.A., Chan K.P., and Wareham N.J. The detection of gene-environment interaction for continuous traits: should we deal with measurement error by bigger studies or better measurement?. Int. J. Epidemiol. 32 (2003) 51-57
48. Grarup N., and Andersen G. Gene-environment interactions in the pathogenesis of type 2 diabetes and metabolism. Curr. Opin. Clin. Nutr. Metab. Care 10 (2007) 420-426
49. Garenc C., Vohl M.C., Bouchard C., and Perusse L. LIPE C-60G influences the effects of physical activity on body fat and plasma lipid concentrations: the Quebec Family Study. Hum. Genom. 3 (2009) 157-168
50. Loos R.J., Rankinen T., Tremblay A., Perusse L., Chagnon Y., and Bouchard C. Melanocortin-4 receptor gene and physical activity in the Quebec Family Study. Int. J. Obes. (Lond.) 29 (2005) 420-428